The long-range objective of this proposal is to understand the immunological pathways responsible for the rejection of xenografts and to develop new therapeutic strategies to prevent this reaction. In the current application, the investigators have chosen to focus on the humoral components of the xenograft reaction in rhesus monkeys as preliminary work they have conducted in humans has demonstrated that antibody responses to xenografts are encoded by a restricted population of germline Ig genes. The applicants have recently hypothesized that xenoreactive antibodies and natural antibodies that mediate rapid immune responses to infectious agents are structurally and functionally related and are both produced by B cells independent of a requirement for T cell help. The investigators' immediate objective for this application, which is the next step in the attainment of their long-range goal, is to validate the use of rhesus monkeys as an experimental model for testing new approaches and treatment strategies for preventing these early phases of the humoral xenograft rejection in patients. The use of Old World primates is currently of limited scientific value as there is almost no direct information available on the nature of the host immune reaction in these species to pig xenografts.
The specific aims of the proposal include a direct comparison of the Ig genes responsible for encoding the xenoantibody response, establishing if identical populations of antibodies are used to mediate rejection of isolated cells and vascularized organ grafts, and which subsets of B cells are used to produce new xenoantibodies. NHPs represent a final and obligatory step in the application of new treatment strategies to human clinical trials and the work described in this proposal directly addresses the usefulness of this experimental model. Understanding the basis for the mechanisms responsible for xenograft rejection in NHPs is critical for: 1) the use of this experimental model as a testing platform for new drug candidates to prevent xenograft rejection prior to their introduction into patients; 2) the development of new therapeutic strategies to prolong xenograft survival that would be impossible to test directly in patients, and 3) the generation of new fundamental information of the nature of the xenograft response in primates.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI052079-03
Application #
6534392
Study Section
Special Emphasis Panel (ZRR1-CM-7 (02))
Program Officer
Kraemer, Kristy A
Project Start
2001-09-30
Project End
2004-06-30
Budget Start
2002-09-01
Budget End
2003-06-30
Support Year
3
Fiscal Year
2002
Total Cost
$261,113
Indirect Cost
Name
Children's Hospital of Los Angeles
Department
Type
DUNS #
094878337
City
Los Angeles
State
CA
Country
United States
Zip Code
90027
Stewart, John M; Tarantal, Alice F; Hawthorne, Wayne J et al. (2015) Clonidine inhibits anti-non-Gal IgM xenoantibody elicited in multiple pig-to-primate models. Xenotransplantation 22:413-26
Chen, Yan; Stewart, John M; Gunthart, Mirja et al. (2014) Xenoantibody response to porcine islet cell transplantation using GTKO, CD55, CD59, and fucosyltransferase multiple transgenic donors. Xenotransplantation 21:244-53
Stewart, John M; Tarantal, Alice F; Chen, Yan et al. (2014) Anti-non-Gal-specific combination treatment with an anti-idiotypic Ab and an inhibitory small molecule mitigates the xenoantibody response. Xenotransplantation 21:254-66
Stewart, John M; Tarantal, Alice F; Hawthorne, Wayne J et al. (2014) Rhesus monkeys and baboons develop clotting factor VIII inhibitors in response to porcine endothelial cells or islets. Xenotransplantation 21:341-52
Harnden, Ivan; Kiernan, Kathleen; Kearns-Jonker, Mary (2010) The anti-nonGal xenoantibody response to alpha1,3-galactosyltransferase gene knockout pig xenografts. Curr Opin Organ Transplant 15:207-11
Kiernan, K; Harnden, I; Gunthart, M et al. (2008) The anti-non-gal xenoantibody response to xenoantigens on gal knockout pig cells is encoded by a restricted number of germline progenitors. Am J Transplant 8:1829-39
Fischer-Lougheed, Jacqueline; Gregory, Clare; White, Zena et al. (2008) Identification of an anti-idiotypic antibody that defines a B-cell subset(s) producing xenoantibodies in primates. Immunology 123:390-7
Fischer-Lougheed, J Y; Tarantal, A F; Shulkin, I et al. (2007) Gene therapy to inhibit xenoantibody production using lentiviral vectors in non-human primates. Gene Ther 14:49-57
Kearns-Jonker, Mary; Barteneva, Natasha; Mencel, Robert et al. (2007) Use of molecular modeling and site-directed mutagenesis to define the structural basis for the immune response to carbohydrate xenoantigens. BMC Immunol 8:3
Zahorsky-Reeves, Joanne L; Kearns-Jonker, Mary K; Lam, Tuan T et al. (2007) The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts. Xenotransplantation 14:135-44

Showing the most recent 10 out of 12 publications